Frutarom Health expands to Latin America
Latin America’s remarkable market size in dietary supplements, pharmaceuticals, cosmetics and functional foods has induced the company to expand into the region, according to the company. The company
Vertex has signed a definitive agreement to purchase Crinetics Pharmaceuticals in a transaction valued at nearly $10bn, or $8.8bn net of estimated cash acquired.
The new office staff, which includes bilingual Mandarin/English speakers, will initially be responsible for supporting clinical studies using ClinPhone randomization and trial supply management (RTSM) and Datalabs EDC